BAG3 and HSPB8 Expression Varies with Amyloid-Beta Plaque Reactivity and Morphology in Alzheimer’s Disease
By Caroline McNinch1,2, Nicholas Mitsios1, Tianyu Zheng1, Jan Mulder1
1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden,
2Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University in St. Louis
School of Medicine, Missouri, USA
https://doi.org/10.55894/dv5.13
Abstract
BAG3 is a stress-responsive co-chaperone implicated in protein quality control and neurodegenerative
disease, yet its cell-type specificity and pathological relevance in the adult human brain remain poorly defined.
This paper provides a comprehensive protein-level characterization of BAG3 and its interaction with the
CASA component HSPB8 in post-mortem human cortex from healthy and neurodegenerative donors. Using
multiplex immunofluorescence, we demonstrate that BAG3 is astrocyte-specific and spans multiple astrocyte
subpopulations. BAG3-HSPB8 exhibits distinct subcellular compartmentalization within astrocyte somas,
suggesting possible CASA-independent functions of BAG3 in astrocyte processes. In Alzheimer’s disease,
BAG3 expression near amyloid-beta plaques varies with plaque morphology and activity. BAG3-HSPB8 is
enriched near active, dense-core plaques, while BAG3 is present without detectable HSPB8 enrichment near
diffuse plaques, suggesting an alternative function. Together, these findings identify astrocytic BAG3 as a
context-dependent regulator of Aβ plaques consistent with dual neuroprotective and potentially pathogenic
roles.Clinic who received angiography between May 1981 and September 1984. Each patient ID includes the
individual patients’ vitals and medical history.